loading...| Preferred Name |
testosterone cypionate |
|
| Synonyms |
Virilon |
|
| Definitions |
An eight-carbon ester form of testosterone. The number of ester carbon atoms correlate with the half-life of the prodrug. Testosterone inhibits gonadotropin secretion from the pituitary gland and ablates estrogen production in the ovaries, thereby decreasing endogenous estrogen levels. In addition, this agent promotes the maintenance of male sex characteristics and is indicated for testosterone replacement in hypogonadal males. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1246" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1246" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000745230 |
|
| altLabel |
Virilon Depotest Pertestis 17beta-cyclopentanepropionate Depovirin Depo-Testosterone depAndro |
|
| CAS Registry |
58-20-8 |
|
| cui |
C1515317 C1515316 C0076181 C1515318 C0719761 C0724290 C0113075 |
|
| DATE FIRST PUBLISHED |
2013-01-17 |
|
| Date last modified |
2013-01-17 |
|
| definition |
An eight-carbon ester form of testosterone. The number of ester carbon atoms correlate with the half-life of the prodrug. Testosterone inhibits gonadotropin secretion from the pituitary gland and ablates estrogen production in the ovaries, thereby decreasing endogenous estrogen levels. In addition, this agent promotes the maintenance of male sex characteristics and is indicated for testosterone replacement in hypogonadal males. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1246" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1246" NCI Thesaurus) |
|
| LT |
TRD |
|
| NCI ID |
C1246 |
|
| notation |
CDR0000745230 |
|
| ORIG STY |
Drug/agent |
|
| prefLabel |
testosterone cypionate |
|
| tui |
T125 T109 T121 |